Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recombinant Human Thyroid Stimulating Hormone”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT01600989
What this trial is testing

Mitochondrial Function of Immune Cells in Sepsis

Who this might be right for
Shock, Septic
Insel Gruppe AG, University Hospital Bern 60
Not applicableStudy completedNCT00439127
What this trial is testing

OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation

Who this might be right for
Differentiated Thyroid Carcinoma
Oncology Institute of Southern Switzerland 28
Testing effectiveness (Phase 2)Study completedNCT00001934
What this trial is testing

Zenapax to Treat Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 22
Post-approval studies (Phase 4)Study completedNCT00001730
What this trial is testing

Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

Who this might be right for
HypothyroidismThyroid Neoplasms
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 20
Large-scale testing (Phase 3)Study completedNCT00196729
What this trial is testing

Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration

Who this might be right for
Thyroid Neoplasms
Genzyme, a Sanofi Company 63
Testing effectiveness (Phase 2)Looking for participantsNCT06300203
What this trial is testing

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Beijing Tongren Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00181168
What this trial is testing

Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Johns Hopkins University 63
Early research (Phase 1)Study completedNCT00137891
What this trial is testing

Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone

Who this might be right for
Healthy
Genzyme, a Sanofi Company 46
Testing effectiveness (Phase 2)Study completedNCT01182285
What this trial is testing

A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin

Who this might be right for
Thyroid Neoplasm
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT05159908
What this trial is testing

Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

Who this might be right for
Focal Onset SeizureFocal Onset Epilepsy
Neurocrine Biosciences 101
Not applicableEnded earlyNCT01412918
What this trial is testing

Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression

Who this might be right for
Tinnitus
Medical College of Wisconsin 21
Testing effectiveness (Phase 2)Study completedNCT00454220
What this trial is testing

Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter

Who this might be right for
Multinodular Goiter
Genzyme, a Sanofi Company 96
Not applicableStudy completedNCT00454077
What this trial is testing

RhTSH-Thyroid Ablation With 1850 MBq of 131I

Who this might be right for
Thyroid Cancer
University of Siena 72
Testing effectiveness (Phase 2)Ended earlyNCT05493293
What this trial is testing

Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

Who this might be right for
Focal Onset SeizureFocal Onset Epilepsy
Neurocrine Biosciences 82
Testing effectiveness (Phase 2)Ended earlyNCT05226780
What this trial is testing

Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE

Who this might be right for
SCN8A Developmental and Epileptic Encephalopathy Syndrome
Neurocrine Biosciences 8
Not applicableLooking for participantsNCT06405217
What this trial is testing

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Who this might be right for
DTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications
Nanjing First Hospital, Nanjing Medical University 30
Large-scale testing (Phase 3)UnknownNCT04964284
What this trial is testing

Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 328
Not applicableLooking for participantsNCT06431620
What this trial is testing

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Who this might be right for
Recombinant Human Thyroid Stimulating Hormone
Nanjing First Hospital, Nanjing Medical University 15
Testing effectiveness (Phase 2)Study completedNCT04137185
What this trial is testing

Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 64
Not applicableEnded earlyNCT02006680
What this trial is testing

Markers of Pubertal Suppression During Therapy for Precocious Puberty

Who this might be right for
Central Precocious Puberty
University of Minnesota 4
Load More Results